NCT07047040

Brief Summary

Evaluation of the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for phase_2

Timeline
20mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Aug 2025Dec 2027

First Submitted

Initial submission to the registry

June 24, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

August 1, 2025

Status Verified

July 1, 2025

Enrollment Period

2.2 years

First QC Date

June 24, 2025

Last Update Submit

July 30, 2025

Conditions

Keywords

total knee replacementpre-operative analgesiaketorolacgabapentin

Outcome Measures

Primary Outcomes (1)

  • evaluate the analgesic efficacy of a pre-operative dose of ketorolac and gabapentin in reducing post-operative pain scores in patients undergoing TKA.

    asses pain postoperatively at 6,12,24 hours using VAS score

    during the first 24 hours post-operatively

Secondary Outcomes (3)

  • assess the impact of pre-operative ketorolac and gabapentin on post-operative opioid consumption

    during the first 24 hours post-operatively

  • investigate the safety profile of pre-operative ketorolac and gabapentin

    during the first 24 hours post-operatively

  • evaluate the effect of pre-operative ketorolac and gabapentin on functional recovery

    during the month after surgery

Study Arms (2)

Experimental group

ACTIVE COMPARATOR

Experimental group will receive single dose of gabapentin 800 mg capsule and ketorolac 30 mg Ampule, one hour prior to administration of spinal anesthesia

Drug: Ketorolac Tromethamine 30 MG/ML Prefilled SyringeDrug: Gabapentin

control group

PLACEBO COMPARATOR

control group will receive normal saline ampule and empty capsule one hour prior to administration of spinal anesthesia

Drug: Empty Medication Capsules

Interventions

a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

Experimental group

a pre-operative dose of ketorolac and gabapentin is given to the patients undergoing unilateral TKA one hour prior to surgery, then a post-operative pain scores will be recorded

Experimental group

two empty capsules of gabapentin

control group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients Undergoing Unilateral Total Knee Replacement from 40 years old to 80 years old

You may not qualify if:

  • Rheumatoid Arthritis History of Renal impairment Patients refused to be enrolled in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University, Faculty of Medicine

Asyut, Asyut Governorate, 71515, Egypt

Location

Related Publications (4)

  • Skinner HB. Multimodal acute pain management. Am J Orthop (Belle Mead NJ). 2004 May;33(5 Suppl):5-9.

    PMID: 15195936BACKGROUND
  • Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15. doi: 10.1097/00000542-199907000-00006.

    PMID: 10422923BACKGROUND
  • Hebl JR, Dilger JA, Byer DE, Kopp SL, Stevens SR, Pagnano MW, Hanssen AD, Horlocker TT. A pre-emptive multimodal pathway featuring peripheral nerve block improves perioperative outcomes after major orthopedic surgery. Reg Anesth Pain Med. 2008 Nov-Dec;33(6):510-7.

    PMID: 19258965BACKGROUND
  • Lee BH, Park JO, Suk KS, Kim TH, Lee HM, Park MS, Lee SH, Park S, Lee JY, Ko SK, Moon SH. Pre-emptive and multi-modal perioperative pain management may improve quality of life in patients undergoing spinal surgery. Pain Physician. 2013 May-Jun;16(3):E217-26.

    PMID: 23703420BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeOsteoarthritis, Knee

Interventions

Ketorolac TromethamineGabapentin

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

IndomethacinIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsAminesOrganic Chemicalsgamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsCyclohexanecarboxylic AcidsAcids, CarbocyclicCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsAmino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Hatem Mohamed Bakr, Professor

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Nour Shaaban Abdel-Aleem, Resident

CONTACT

Mohamed Ahmed Mahran, Professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients scheduled for unilateral total knee replacement ranging from 40-80 years of age will be selected. Patients will be randomized into two groups. Experimental group will receive single dose of gabapentin 800 mg capsule and ketorolac 30 mg Ampule. While control group will receive normal saline ampule and empty capsule one hour prior to administration of spinal anesthesia. Pain will be assessed postoperatively by visual analogue score at,6 hours, 12 hours and 24 hours. total dose of analgesia in first 24 hours will be recorded. Any complications will be recorded in first 24 hours post- operative period. Follow up: Visual Analog Scale (VAS) will be used at 6, 12, 24 hours post-surgery for assessment of Pain. Any side effects or complications will be recorded. Time Up and Go (TUG) test after 24hrs post-operative. Oxford knee score (OKS) after 4 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 2, 2025

Study Start

August 15, 2025

Primary Completion (Estimated)

October 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

August 1, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations